Species differences in the effects of prostanoids on MAP kinase phosphorylation, myosin light chain phosphorylation and contraction in bovine and cat iris sphincter smooth muscle

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 72, Issue 1, 2005, Pages 49-57

  Kaddour Djebbar, I ^a   Ansari, H R ^a   Akhtar, R A ^a   Abdel Latif, A A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; LATANOPROST; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID;

ANIMAL TISSUE; ARTICLE; CAT; CATTLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SPECIES DIFFERENCE; SPHINCTER PUPILLAE MUSCLE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CATS; CATTLE; DINOPROST; DINOPROSTONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IRIS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; PROSTAGLANDINS; PROSTAGLANDINS F, SYNTHETIC; SPECIES SPECIFICITY;

BOVINAE; FELIS CATUS;

EID: 10344238551     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2004.10.001     Document Type: Article

References (30)

1. R.A. Coleman, I. Kennedy, P.P.A. Humprey, K. Bunce, and P. Lumley Prostanoids and their receptors C. Hausch P.G. Sammes J.B. Taylor Comprehensive Medicinal Chemistry 1990 Pergamon Oxford 643 714
2. L.Z. Bito, J. Stjernschantz (Eds), The Ocular Effects of Prostaglandins and Other Eicosanoids, Alan R. Liss, Inc. 1989.
3. A.A. Abdel-Latif Release and effects of prostaglandins in ocular tissues Prostaglandins, Leukot. Essent. Fatty Acids 44 1991 71 82
4. L.Z. Bito A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond Invest. Ophthalmol. Vis. Sci. 42 2001 1126 1133
5. 2α-isopropyl ester to latanoprost a review of the development of xalatan Invest. Ophthalmol. Vis. Sci. 42 2001 1134 1145
6. α increases uveoscleral outflow in the cynomolgus monkey Exp. Eye Res. 49 1989 389 402
7. A.A. Abdel-Latif Phosphoinositide and arachidonic acid signaling systems in the mammalian iris Prog. Retinal Eye Res. 14 1995 75 107
8. R.A. Coleman, W.L. Smith, and S. Narumiya VIII International Union of Pharmacology, classification of prostanoid receptors properties, distribution, and structure of the receptors and their subtypes Pharmacol. Rev. 46 1994 205 229
9. I. Kennedy, R.A. Coleman, P.P.A. Humphrey, G.P. Levy, and P. Lumley Studies on the characterization of prostanoid receptors: a proposed classification. Prostaglandins 24 1982 667 689
10. H. Toh, A. Ichikawa, and S. Narumiya Molecular evolution of receptors for eicosanoids FEBS Lett. 361 1995 17 22
11. M. Abramovitz, M. Adam, Y. Bole, R. Grygorczk, T.H. Rushmore, T. Nguyen, C.D. Funk, N. Sawyer, C. Rochette, D.M. Slippetz, and K.M. Metters Human prostanoid receptors cloning and characterization Adv. Prostaglandin Thromboxane Leukot. Res. 23 1995 499 504
12. K.L. Pierce, D.W. Gil, D.F. Woodward, and J.W. Regan Cloning of human prostanoid receptors Trends Pharmacol. Sci. 16 1995 253 256
13. A.A. Abdel-Latif Minireview cross talk between cyclic nucleotides and polyphos-inositide hydrolysis, protein kinases and contraction in smooth muscle Exp. Biol. Med. 226 2001 153 163
14. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors Structures, properties, and functions Physiol. Rev. 79 1999 1193 1226
15. G.W.H.M. Van Alphen, P.B. Wilhelm, and P.W. Elsenfeld The effect of prostaglandins on the isolated internal muscles of the mammalian eye, including man Documenta Ophtalmol. 42 1977 397 415
16. Y.J. Dong, and R.L. Jones Effects of prostaglandins and thromboxane analogues on bullock and dog iris sphincter preparations Br. J. Pharmacol. 76 1982 149 155
17. S.Y.K. Yousufzai, A.-L. Chen, and A.A. Abdel-Latif Species differences in the effects of prostaglandins on inositol triphosphate accumulation, phosphatidic acid formation, myosin light chain phosphorylation and contraction in iris sphincter of the mammalian eye interaction with the cAMP system J. Pharmacol. Exp. Ther. 247 1998 1064 1072
18. P. Bhattacherjee, M. Smithson, and C.A. Paterson Generation of second messengers by prostanoids in the iris-sphincter and ciliary muscles of cows, cats and humans Prostaglandins Leukot. Essent. Fatty Acids 56 1997 443 449
19. B. Tran, L.C. Blueback, and P.L. Kaufman ML-7, Chelerythrine, and phorbol ester increase outflow facility in the monkey eye Exp. Eye Res. 71 2000 551 566
20. M. Honjo, M. Inatani, N. Kido, T. Sawamura, Y. Beatrice, J.T. Yue, Y. Honda, and H. Taninara A myosin light chain kinase inhibitor, ML-9, lowers intraocular pressure in rabbit eyes Exp. Eye Res. 75 2002 135 142
21. 2α and latanoprost on phosphoinositide turnover, myosin light chain phosphorylation and contraction in cat iris sphincter J. Ocular Pharmacol. Ther. 19 2003 217 231
22. 2α, latanoprost and carbachol on phosphoinositide turnover, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter Exp. Eye Res. 78 2004 285 296
23. P.H. Howe, R.A. Akhtar, S. Naderi, and A.A. Abdel-Latif Correlative studies on the effect of carbachol on myo-inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris J. Pharmacol. Exp. Ther. 239 1986 574 583
24. 2 in cat iris sphincter smooth muscle cells Biochem. J. 342 1999 87 94
25. 2α, ionomycin, and thapsigargin in cat iris sphincter smooth muscle inhibition by PD98059, KN-93, and isoproterenol J. Pharmacol. Exp. Ther. 299 2001 178 186
26. K.E. Kamm, and J.T. Stull The function of myosin light chain kinase phosphorylation in smooth muscle Ann. Rev. Pharmacol. Toxicol. 25 1985 593 620
27. R. Williams, A. Mc Connell, C. A. Opere, S. E. Ohia, Prostanoid FP-receptors in the isolated iris. Fed. Am. Soc. Exp. Biol. (FASEB) J. 17 (2003) Abst. # 399.14.
28. 2α binding sites in the bovine iris ciliary body Invest. Ophtalmol. Vis. Sci. 34 1993 2237 2245
29. P. Bhattacherjee, B.S. Williams, P. Mukhopadhyay, and C.A. Patterson Bovine iris-sphincter muscle lacks FP receptor binding sites Ocular Immunol. Inflamm. 7 1999 39 50
30. W.G. Unger, Mediaton of the ocular response to injury and irritation: peptides versus prostaglandins, in: L.Z. Bito, J. Stjernschantz (Eds.), The Ocular Effects of Prostaglandins and other Eicosanoids, Alan R. Liss, inc., 1989. pp. 293-328.